BlackRock Health Sciences Trust Past Earnings Performance
Past criteria checks 1/6
BlackRock Health Sciences Trust's earnings have been declining at an average annual rate of -20.9%, while the Capital Markets industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 13.5% per year. BlackRock Health Sciences Trust's return on equity is 3.4%, and it has net margins of 244.3%.
Key information
-20.9%
Earnings growth rate
-24.7%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | 13.5% |
| Return on equity | 3.4% |
| Net Margin | 244.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
BME: Trading At A Historical Discount To NAV
Apr 05BME: Historically One Of The Best Times For Entry
Nov 28BME: BlackRock's Health Sciences Fund Is A Solid Alternative To Pricey THW
Sep 17BME Offers A Good Mix Of High Yield And Market-Beating Total Returns
Jul 03BME: Well-Positioned Healthcare CEF For Monthly Income
Feb 10BlackRock Health Sciences Trust declares $0.213 dividend
Dec 12BlackRock Health Sciences Trust goes ex-dividend on Monday
Nov 11BlackRock Health Sciences Trust declares $0.213 dividend
Oct 06BME: Overpriced Health-Care CEF, Paltry 6% Yield
Sep 21BlackRock Health Sciences Trust declares $0.213 dividend
Sep 02BlackRock Health Sciences Trust declares $0.213 dividend
Aug 05BME And BMEZ: 2 Quite Different Choices
Jul 26BlackRock Health Sciences Trust declares $0.213 dividend
Jul 05BME: Good Times, Bad Times, A Fund For All Times
Apr 24BME: High Concentration In Large Cap Led To Huge Downfall
Mar 03BMEZ: We Own BME, But Here's Why We're Buying BlackRock Health Sciences Trust II
Dec 24BME: High Yield And Strong Growth From Healthcare
Dec 14BlackRock Health Sciences: Clever Options Strategies And Asset Allocation
Sep 19Evaluating CEFs: BME Offers Good Income In A Hot Sector
Jun 18BlackRock Health Sciences Trust declares $0.20 dividend
May 07BlackRock Health Sciences Trust declares $0.20 dividend
Feb 04BlackRock Health Sciences Trust declares $0.20 dividend
Jan 05BME: Monthly Dividends Plus Growth
Dec 15BlackRock Health Sciences Trust declares $0.20 dividend
Dec 04BlackRock Health Sciences Trust declares $0.20 dividend
Nov 03Revenue & Expenses BreakdownBeta
How BlackRock Health Sciences Trust makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 8 | 20 | 6 | 0 |
| 30 Sep 23 | 8 | 34 | 6 | 0 |
| 30 Jun 23 | 8 | 47 | 6 | 0 |
| 31 Mar 23 | 8 | 10 | 6 | 0 |
| 31 Dec 22 | 8 | -26 | 6 | 0 |
| 30 Sep 22 | 7 | -35 | 6 | 0 |
| 30 Jun 22 | 7 | -43 | 6 | 0 |
| 31 Mar 22 | 7 | 8 | 6 | 0 |
| 31 Dec 21 | 6 | 59 | 6 | 0 |
| 30 Sep 21 | 6 | 84 | 6 | 0 |
| 30 Jun 21 | 6 | 109 | 6 | 0 |
| 31 Mar 21 | 5 | 94 | 6 | 0 |
| 31 Dec 20 | 5 | 80 | 5 | 0 |
| 30 Sep 20 | 5 | 67 | 5 | 0 |
| 30 Jun 20 | 5 | 55 | 5 | 0 |
| 31 Mar 20 | 5 | 67 | 4 | 0 |
| 31 Dec 19 | 5 | 80 | 4 | 0 |
| 30 Sep 19 | 5 | 59 | 4 | 0 |
| 30 Jun 19 | 5 | 39 | 4 | 0 |
| 31 Mar 19 | 5 | 31 | 4 | 0 |
| 31 Dec 18 | 5 | 22 | 4 | 0 |
| 30 Sep 18 | 4 | 28 | 4 | 0 |
| 30 Jun 18 | 4 | 34 | 4 | 0 |
| 31 Mar 18 | 4 | 47 | 4 | 0 |
| 31 Dec 17 | 4 | 60 | 3 | 0 |
| 30 Sep 17 | 4 | 50 | 3 | 0 |
| 30 Jun 17 | 3 | 39 | 3 | 0 |
| 31 Mar 17 | 3 | 11 | 3 | 0 |
| 31 Dec 16 | 3 | -16 | 3 | 0 |
| 30 Sep 16 | 3 | -18 | 3 | 0 |
| 30 Jun 16 | 3 | -21 | 3 | 0 |
| 31 Mar 16 | 3 | 6 | 4 | 0 |
| 31 Dec 15 | 3 | 33 | 4 | 0 |
| 31 Dec 14 | 3 | 50 | 3 | 0 |
| 31 Oct 14 | 3 | 71 | 3 | 0 |
| 31 Jul 14 | 3 | 61 | 3 | 0 |
| 30 Apr 14 | 3 | 50 | 3 | 0 |
| 31 Jan 14 | 4 | 60 | 3 | 0 |
| 31 Oct 13 | 4 | 69 | 3 | 0 |
| 31 Jul 13 | 4 | 61 | 3 | 0 |
Quality Earnings: BME has a large one-off gain of $17.5M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: BME became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BME's earnings have declined by 20.9% per year over the past 5 years.
Accelerating Growth: BME has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: BME has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (3.3%).
Return on Equity
High ROE: BME's Return on Equity (3.4%) is considered low.